Qyuns Therapeutics Co (HKSE:02509) Construction In Progress : HK$0.5 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co Construction In Progress?

Qyuns Therapeutics Co's quarterly construction in progress declined from Dec. 2023 (HK$2.1 Mil) to Jun. 2024 (HK$0.0 Mil) but then increased from Jun. 2024 (HK$0.0 Mil) to Dec. 2024 (HK$0.5 Mil).

Qyuns Therapeutics Co's annual construction in progress declined from Dec. 2022 (HK$8.6 Mil) to Dec. 2023 (HK$2.1 Mil) and declined from Dec. 2023 (HK$2.1 Mil) to Dec. 2024 (HK$0.5 Mil).

Qyuns Therapeutics Co Construction In Progress Historical Data

The historical data trend for Qyuns Therapeutics Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co Construction In Progress Chart

Qyuns Therapeutics Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Construction In Progress

8.70

8.65

2.14

0.46

Qyuns Therapeutics Co Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Jun24	Dec24
Construction In Progress	Get a 7-Day Free Trial			8.65	2.97	2.14	-	0.46

Qyuns Therapeutics Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Qyuns Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN

Website

http://www.qyuns.net

Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline. It has built a pipeline that covers the four disease areas in the field, including skin, rheumatic, respiratory and digestive diseases Key revenue is generated from PRC.

Executives

Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Tai Zhou Jian Xin Chuang Ye Tou Zi You Xian Gong Si	2101 Beneficial owner
Hang Zhou Zhong Mei Hua Dong Zhi Yao You Xian Gong Si	2101 Beneficial owner
Zhong Guo Yuan Da Ji Tuan You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Yuan Da Hua Chuang Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Hua Dong Yi Yao Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Qiu Jiwan
Xu Qiu
Hangzhou Quanyi Investment Management Partnership (general Partnership)
Yu Guo'an
Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Sheng Xi Tai

Qyuns Therapeutics Co Headlines

No Headlines